title: [Prognostic implictions of the lack of a lipid-lowering strategy].
authors.affiliation: Klinikum der Universität Regensburg, Klinik und Poliklinik für Innere Medizin II, Franz-Josef-Strauss-Allee 11, D-93053 Regensburg.
authors.forename: A
authors.initials: A
authors.lastname: Baessler
authors.forename: M
authors.initials: M
authors.lastname: Fischer
authors.forename: U
authors.initials: U
authors.lastname: Hubauer
authors.forename: K
authors.initials: K
authors.lastname: Stark
authors.forename: W
authors.initials: W
authors.lastname: Hengstenberg
authors.forename: S
authors.initials: S
authors.lastname: Wiedmann
authors.forename: K
authors.initials: K
authors.lastname: Neureuther
authors.forename: S
authors.initials: S
authors.lastname: Holmer
authors.forename: B
authors.initials: B
authors.lastname: Mayer
authors.forename: H
authors.initials: H
authors.lastname: Schunkert
authors.forename: C
authors.initials: C
authors.lastname: Hengstenberg
mesh_terms: D008078:Cholesterol, LDL / Q000097:blood*; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000401:mortality; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D055502:Secondary Prevention; D015996:Survival Rate
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors